Karl Weiss

From Lab to Bedside Testing: Uncovering Gateways and Roadblocks to Syndromic Multiplex Point-of-Care Testing for Infectious Diseases in Canadian Hospitals.

Augustyniak M, Isber J, Shaw J, Weiss K, Lazure P

Strategies to reduce 28-day mortality in adult patients with bacteremia in the emergency department.

Laurier N, Karellis A, Xue X, Afilalo M, Weiss K

Anaplasmosis encephalitis and infection of non-myeloid bone marrow precursors.

Sohani Z, Zhao N, Weiss K, Knecht H

Phylogenetic Clustering among Asylum Seekers with New HIV-1 Diagnoses in Montreal, QC, Canada.

Park H, Brenner B, Ibanescu RI, Cox J, Weiss K, Klein MB, Hardy I, Narasiah L, Roger M, Kronfli N

Progressive disseminated histoplasmosis in an apparently immunocompetent patient with a bioprosthetic aortic valve.

Lieu A, Parkes LO, Longtin Y, Weiss K, Zaharatos GJ

Prevalence of antibiotic-resistant organisms in Canadian Hospitals. Comparison of point-prevalence survey results from 2010, 2012, and 2016.

Martin P, Abou Chakra CN, Williams V, Bush K, Dyck M, Hirji Z, Kiss A, Larios OE, McGeer A, Moore C, Weiss K, Simor AE, Infection Prevention and Control Canada

Vaccine strategies for prevention of community-acquired pneumonia in Canada: Who would benefit most from pneumococcal immunization?

Alan G. Kaplan, Pierre Arsenault, Brian Aw, Vivien Brown, George A Fox, Ron Grossman, Taj Jadavji, Craig A. Laferrière, Suzanne Levitz, Mark B Loeb, Andrew McIvor, Christopher H. Mody, Yannick Poulin, Marla Shapiro, Dominique Tessier, Francois Théorêt, Karl Heinz Weiss, John Yaremko, George G. Zhanel

Determinants of Outcome in Hospitalized Patients With Methicillin-Resistant Staphylococcus aureus Bloodstream Infection: Results From National Surveillance in Canada, 2008-2012.

Simor AE, Pelude L, Golding G, Fernandes R, Bryce E, Frenette C, Gravel D, Katz K, McGeer A, Mulvey MR, Smith S, Weiss K, Canadian Nosocomial Infection Surveillance Program

Fidaxomicin versus Vancomycin in the Treatment of<i>Clostridium difficile</i>Infection: Canadian Outcomes

Effects of proton pump inhibitors and histamine-2 receptor antagonists on response to fidaxomicin or vancomycin in patients with Clostridium difficile-associated diarrhoea.

Weiss K, Louie T, Miller MA, Mullane K, Crook DW, Gorbach SL